Our latest webinar starts on Tuesday 26 January at 18:00. We are joined by guest speakers from Orosur Mining, Savannah Resources, Rainbow Rare Earths and Goldplat. Register here.

Less Ads, More Data, More Tools Register for FREE
Hardman Healthcare Index - Life Sciences, where the smart money was in an 'exceptional' 2020
Hardman Healthcare Index - Life Sciences, where the smart money was in an 'exceptional' 2020View Video

Pin to quick picksPlethora Solutions Holdings Plc Regulatory News (PLE)

  • There is currently no data for PLE

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Director/PDMR Shareholding

Tue, 9th Feb 2016 15:24

RNS Number : 5620O
Plethora Solutions Holdings PLC
09 February 2016
 

Plethora Solutions Holdings PLC

("Plethora" or the "Company")

Director Shareholding

 

Plethora Solutions Holdings PLC (AIM: PLE) was notified on 8 February 2016 that the liquidator of ARBB AG ("ARBB"), a company that is in voluntary liquidation, autonomously completed the disposal of 1,600,000 ordinary shares in aggregate in the Company (representing approximately 0.19 per cent. of the issued share capital of the Company) on 2 February 2016 at an average price of 3.61 pence per share realising £57,719 for meeting its liquidation costs.

40.91 per cent. of the issued share capital of ARBB is owned by Burnbrae Ltd, which is 100% beneficially owned by James Mellon. However, James Mellon exercises no control over ARBB as full control is being exercised by the liquidators.

Following this disposal ARBB no longer holds any shares in Plethora.

 

James Mellon's current interest in ordinary shares in the Company, including those held through Regent Pacific Group Limited, is 242,158,261 ordinary shares representing 29.41 per cent. of the Company. 

 

-Ends-

 

Plethora Solutions

Jamie Gibson, CEO

Mike Wyllie, CSO

 

Tel : +44(0) 20 3077 5400

finnCap (Nomad & Broker)

Geoff Nash/James Thompson

Stephen Norcross

Tel : +44(0) 20 7220 0500

(Corporate Finance)

(Corporate Broking)

Citigate Dewe Rogerson

David Dible

Malcolm Robertson

 

Tel: +44(0) 20 7282 2949

Tel: +44(0) 20 7282 2867

 

About Plethora

Plethora is headquartered in the UK and is listed on the London Stock Exchange (AIM: PLE LN). Further information is available at www.plethorasolutions.co.uk 

Plethora is focused on commercializing PSD502™ for the treatment of premature ejaculation with strategic marketing partners and obtaining NDA approval for PSD502™ with the FDA.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFFEFVIAIIR
Date   Source Headline
9th Mar 20168:15 amRNSScheme becomes Effective
8th Mar 20164:44 pmRNSCourt Sanction of Scheme - Replacement
8th Mar 20163:12 pmRNSScheme becomes Effective
8th Mar 201611:59 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
8th Mar 20167:30 amRNSSuspension - Plethora Solutions Holdings Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.